Perspective Therapeutics (CATX) Change in Accured Expenses (2010 - 2026)

Perspective Therapeutics has disclosed Change in Accured Expenses across 17 years of filings, most recently posting $632000.0 for Q2 2026.

• In Q2 2026, Change in Accured Expenses rose 131.89% year-over-year to $632000.0; the TTM figure through Jun 2026 stood at $3.0 million (up 799.7% YoY), while the FY2025 annual figure was $2.0 million, down 44.14% from the prior year.
• Change in Accured Expenses came in at $632000.0 for Q2 2026 at Perspective Therapeutics, up from -$4.2 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $16.2 million in Q3 2024 to a low of -$11.3 million in Q4 2024.
• Average Change in Accured Expenses over 5 years is $325777.8, with a median of $477000.0 recorded in 2023.
• Year-over-year, Change in Accured Expenses surged 4017.5% in 2022 and sank 2496.83% in 2024.
• Over 5 years, Change in Accured Expenses stood at $573000.0 in 2022, then decreased by 17.45% to $473000.0 in 2023, then slumped by 2496.83% to -$11.3 million in 2024, then soared by 106.86% to $778000.0 in 2025, then dropped by 18.77% to $632000.0 in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $632000.0 in Q2 2026, -$4.2 million in Q1 2026, and $778000.0 in Q4 2025.